4 Drug Stocks Facing FDA Approval Decisions in July

Description:

According to Adam Feuerstein, " Four FDA drug approval decisions in July -- headlined by another weight-loss drug and a prescription fish oil pill with blockbuster potential -- will keep biotech investors busy in what is normally one of the sector's slower months." Read more here.

>>Also: Hot Biotech Stocks Traded by Hedge Funds

>>Also: 22 Biopharma Stocks With Breakout Potential in 2012

Most Viewed Portfolios

View All

Articles

4 Huge Stocks Ripe for a Sharp Pullback

05.24.13 | 02:37 PM

NEW YORK (Stockpickr) -- Market strategists talk about two kinds of stock market environments: "risk-on" and "risk-off." In a risk-off market,...

3 Tech Stocks Spiking on Big Volume

05.24.13 | 02:26 PM

MADISON, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track b...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter